MicroRNA-451a inhibits gemcitabine-refractory biliary tract cancer progression by suppressing the MIF-mediated PI3K/AKT pathway
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNA-451a inhibits gemcitabine-refractory biliary tract cancer progression by suppressing the MIF-mediated PI3K/AKT pathway
Authors
Keywords
-
Journal
Molecular Therapy-Nucleic Acids
Volume -, Issue -, Pages 102054
Publisher
Elsevier BV
Online
2023-10-28
DOI
10.1016/j.omtn.2023.102054
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- How I treat biliary tract cancer
- (2022) A. Lamarca et al. ESMO Open
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Epigenetic silencing of miR-144/451a cluster contributes to HCC progression via paracrine HGF/MIF-mediated TAM remodeling
- (2021) Junlong Zhao et al. Molecular Cancer
- Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial
- (2021) Angela Lamarca et al. LANCET ONCOLOGY
- MicroRNA: A signature for cancer progression
- (2021) Bashdar Mahmud Hussen et al. BIOMEDICINE & PHARMACOTHERAPY
- The current landscape of nucleic acid therapeutics
- (2021) Jayesh A. Kulkarni et al. Nature Nanotechnology
- Extracellular vesicle-shuttled miRNAs as a diagnostic and prognostic biomarker and their potential roles in gallbladder cancer patients
- (2021) Eijiro Ueta et al. Scientific Reports
- MiR-451a attenuates doxorubicin resistance in lung cancer via suppressing epithelialmesenchymal transition (EMT) through targeting c-Myc
- (2020) Li Tao et al. BIOMEDICINE & PHARMACOTHERAPY
- Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours
- (2020) David S. Hong et al. BRITISH JOURNAL OF CANCER
- Cholangiocarcinoma 2020: the next horizon in mechanisms and management
- (2020) Jesus M. Banales et al. Nature Reviews Gastroenterology & Hepatology
- Therapeutic advances of miRNAs: A preclinical and clinical update
- (2020) Chiranjib Chakraborty et al. Journal of Advanced Research
- Phase 2 study of copanlisib in combination with gemcitabine and cisplatin in advanced biliary tract cancers
- (2020) Elaine S. Tan et al. CANCER
- Kras-driven heterotopic tumor development from hepatobiliary organoids
- (2019) Masako Ochiai et al. CARCINOGENESIS
- Evolving complexity of MIF signaling
- (2019) Stanislovas S. Jankauskas et al. CELLULAR SIGNALLING
- miRDB: an online database for prediction of functional microRNA targets
- (2019) Yuhao Chen et al. NUCLEIC ACIDS RESEARCH
- miRPathDB 2.0: a novel release of the miRNA Pathway Dictionary Database
- (2019) Tim Kehl et al. NUCLEIC ACIDS RESEARCH
- Impact of novel oncogenic pathways regulated by antitumor miR-451a in renal cell carcinoma
- (2018) Yasutaka Yamada et al. CANCER SCIENCE
- EMT Subtype Influences Epithelial Plasticity and Mode of Cell Migration
- (2018) Nicole M. Aiello et al. DEVELOPMENTAL CELL
- miRBase: from microRNA sequences to function
- (2018) Ana Kozomara et al. NUCLEIC ACIDS RESEARCH
- Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study
- (2017) Nico van Zandwijk et al. LANCET ONCOLOGY
- EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
- (2017) Tsukasa Shibue et al. Nature Reviews Clinical Oncology
- MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
- (2017) Rajesha Rupaimoole et al. NATURE REVIEWS DRUG DISCOVERY
- FolamiRs: Ligand-targeted, vehicle-free delivery of microRNAs for the treatment of cancer
- (2017) Esteban A. Orellana et al. Science Translational Medicine
- Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
- (2016) J. W. Valle et al. ANNALS OF ONCOLOGY
- 3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained
- (2016) Michele Zanoni et al. Scientific Reports
- Macrophage migration inhibitory factor - a therapeutic target in gallbladder cancer
- (2015) Tejaswini Subbannayya et al. BMC CANCER
- SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathway
- (2015) Yi-Jun Shu et al. Molecular Cancer
- Genomic spectra of biliary tract cancer
- (2015) Hiromi Nakamura et al. NATURE GENETICS
- MYC, Metabolism, and Cancer
- (2015) Z. E. Stine et al. Cancer Discovery
- Spherical Cancer Models in Tumor Biology
- (2015) Louis-Bastien Weiswald et al. NEOPLASIA
- Macrophage migration inhibitory factor engages PI3K/Akt signalling and is a prognostic factor in metastatic melanoma
- (2014) Camila S Oliveira et al. BMC CANCER
- MicroRNA-451 induces epithelial–mesenchymal transition in docetaxel-resistant lung adenocarcinoma cells by targeting proto-oncogene c-Myc
- (2014) Dongqin Chen et al. EUROPEAN JOURNAL OF CANCER
- Signaling mechanisms of the epithelial-mesenchymal transition
- (2014) D. M. Gonzalez et al. Science Signaling
- Deadly crosstalk: Notch signaling at the intersection of EMT and cancer stem cells
- (2013) Ingrid Espinoza et al. CANCER LETTERS
- Pharmacological inhibition of macrophage migration inhibitory factor interferes with the proliferation and invasiveness of squamous carcinoma cells
- (2013) NADÈGE KINDT et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The Potential Role of miR-451 in Cancer Diagnosis, Prognosis, and Therapy
- (2013) X. Pan et al. MOLECULAR CANCER THERAPEUTICS
- Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy
- (2013) Supak Yothaisong et al. TUMOR BIOLOGY
- Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma
- (2012) Naotake Funamizu et al. INTERNATIONAL JOURNAL OF CANCER
- Activation of the AKT/cyclin D1/Cdk4 survival signaling pathway in radioresistant cancer stem cells
- (2012) T Shimura et al. Oncogenesis
- Upregulation of microRNA-451 increases cisplatin sensitivity of non-small cell lung cancer cell line (A549)
- (2011) Hai-Bo Bian et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Cholangiocarcinoma—controversies and challenges
- (2011) Tushar Patel Nature Reviews Gastroenterology & Hepatology
- MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14)
- (2011) R Wang et al. ONCOGENE
- The Promise of MicroRNA Replacement Therapy
- (2010) A. G. Bader et al. CANCER RESEARCH
- Defective erythroid differentiation in miR-451 mutant mice mediated by 14-3-3
- (2010) D. M. Patrick et al. GENES & DEVELOPMENT
- Wnt activity defines colon cancer stem cells and is regulated by the microenvironment
- (2010) Louis Vermeulen et al. NATURE CELL BIOLOGY
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
- (2010) Juan Valle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of PI3K increases oxaliplatin sensitivity in cholangiocarcinoma cells
- (2009) Kawin Leelawat et al. Cancer Cell International
- The Expression of Phospho-AKT, Phospho-mTOR, and PTEN in Extrahepatic Cholangiocarcinoma
- (2009) J.-Y. Chung et al. CLINICAL CANCER RESEARCH
- Expression of phospho-ERK1/2 and PI3-K in benign and malignant gallbladder lesions and its clinical and pathological correlations
- (2009) Qinglong Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells
- (2009) Kyoung-Ok Hong et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Spheroid-based drug screen: considerations and practical approach
- (2009) Juergen Friedrich et al. Nature Protocols
- MicroRNAs in Cancer
- (2008) Yong Sun Lee et al. Annual Review of Pathology-Mechanisms of Disease
- The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations
- (2008) A. Dubrovska et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PI-3K/Akt Pathway-Dependent Cyclin D1 Expression Is Responsible for Arsenite-Induced Human Keratinocyte Transformation
- (2007) Weiming Ouyang et al. ENVIRONMENTAL HEALTH PERSPECTIVES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now